Facebook Linkedin Twitter
Inside Precision Medicine Anti-Inflammatory Marker Holds Promise for Cardiovascular Vaccine

Vaccines

Human heart
News & Features

Anti-Inflammatory Marker Holds Promise for Cardiovascular Vaccine

Anita Chakraverty
0
Gloved hand holding COVID-19 vaccine such as the mRNA vaccine developed by Arcturus Therapeutics in syringe on a background of SARS-CoV-2 particles
Coronavirus

Arcturus’ COVID-19 Vaccine Triggers Enhanced Immune Response

0
3d illustration of a cancer cell. Medical concept.
News & Features

Quad Moonshot First Targets Cervical Cancer

0
Cancer immunotherapy research concept
News & Features

UCLA Receives $120 Million Gift to Establish the California Institute for Immunology and Immunotherapy

0
Female doctor taking swab test of male patient in clinic during COVID-19
Coronavirus

COVID-19 Nasal Vaccine Ready for Clinical Trials

0
Lung Cancer
News & Features

Global Trial of BioNTech’s mRNA-Based Lung Cancer Vaccine Launches

0
Green and blue coronavirus cells under magnification intertwined with DNA cell structure
Coronavirus

Higher Mental Illness Risk among Unvaccinated after Severe Bouts of COVID-19 

0
Single strand ribonucleic acid, RNA research
Coronavirus

TriLink Cuts Ribbon to mRNA Production Facility for Medical Countermeasures

Jonathan D. Grinstein, PhD
0
Monkeypox virus
News & Features

As Mpox Clades Cross Borders, WHO Declares Global Public Health Emergency

0
3D image illustrating immune cells attacking cancer cells in immunotherapy such as that used in cancers with mismatch repair deficiency
News & Features

BioNTech’s mRNA Vaccine Combo Scores in Phase II

0
123...24Page 1 of 24

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine